Continuous venovenous hemofiltration: Effects on monocyte and lymphocyte immunophenotype in critically ill patients

International Journal of Artificial Organs

Volumn 25, Issue 11, 2002, Pages 1066-1073

  Rokyta, Richard ^a   Holub, M ^b,c   Matejovic M ^a   Hanzlikova J ^a   Helcl, M ^b   Novak I ^a   Sramek V ^a   Krouzecky A ^a   Prihodova J ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c WADSWORTH CENTER   (United States)

Author keywords

Acute renal failure; Flow cytometry; Hemofiltration; HLA DR expression; Lymphocyte; Monocyte; Sepsis

Indexed keywords

BODY FLUIDS; INTENSIVE CARE UNITS; T-CELLS;

ACUTE RENAL FAILURE; CRITICALLY-ILL PATIENTS; HEMOFILTRATION; HLA-DR EXPRESSION; IMMUNOPHENOTYPES; MONOCYTE; RENAL FAILURE; SEPSIS; T LYMPHOCYTES; WHITE CELL;

FLOW CYTOMETRY;

CD14 ANTIGEN; CD3 ANTIGEN; HLA DR ANTIGEN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HEMOFILTRATION; HUMAN; HYPOTHESIS; IMMUNOLOGICAL PROCEDURES; IMMUNOPHENOTYPING; INTENSIVE CARE UNIT; LEUKOCYTE; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MEASUREMENT; MONOCYTE; PROSPECTIVE STUDY; SEPSIS; T LYMPHOCYTE; ULTRAFILTRATION;

EID: 0036866433     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880202501105     Document Type: Article

References (27)

1. Bellomo R, Ronco C. Continuous renal replacement therapy in the intensive care unit. Intens Care Med 1999; 25: 781-9.
2. Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993; 21: 522-6.
3. Van Deuren M, Van Der Meer JWM. Hemofiltration in septic patients is not able to alter the plasma concentrations of cytokines therapeutically. Intens Care Med 2000; 26: 1176-8.
4. De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999; 10: 846-53.
5. Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady JJ, Pinsky MR. Diffusive vs. convective therapy: Effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 1998; 26: 1995-2000.
6. Salmon J, Cardigan R, Mackie I. Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways. Intens Care Med 1997; 23: 38-43.
7. Toft P, Kehler D, Brandslund I, Tonnsen E. The immunological effects of continuous veno-venous haemodiafiltration in critically ill patients. Crit Care 1999; 3: 159-65.
8. Lonnemann G, Bechstein M, Linnenweber S, Burg M, Koch KM. Tumor necrosis factor-α during continuous high-flux hemodialysis in sepsis with acute renal failure. Kidney Int 1999; 72 (suppl): S84-7.
9. Yekebas EF, Eisenberger CF, Ohnesorge H, et al. Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med 2001; 29: 1423-30.
10. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine consensus conference. Definition for sepsis and organ failure and guidelines for the way of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74.
11. Moreno R, Vincent JL, Matos R, et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working group on sepsis related problems of the ESICM. Intens Care Med 1999; 25: 686-96.
12. Grooteman MP, Nubé MJ, Van Limbeek J, Schoorl M, Van Houte AJ. Lymphocyte subsets in dialyser eluates: A new parameter of bioincompatibility? Nephrol Dial Transplant 1996; 11: 1073-8.
13. Volk HD, Reinke P, Docke WD. Immunostimulation with cytokines in patients with "immunoparalysis". In: Marshall JC, Cohen J, eds. Immune Response in the Critically Ill. Springer, Berlin, Heidelberg, New York, 1999: pp. 393-404.
14. Bone RC. Immunological dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 1996; 125: 680-7.
15. Adrie C, Pinsky MR. The inflammatory balance in human sepsis. Intens Care Med 2000; 26: 364-75.
16. Döcke WD, Randwo F, Syrbe U, et al. Monocyte deactivation in septic patients: Restoration by INF-γ treatment. Nat Med 1997; 3: 678-81.
17. Kox WJ, Bone RC, Krausch D, et al. Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. Arch Intern Med 1997; 157: 389-93.
18. Schiller B, Ziegler-Heitbrock HWL, Meyer N, Schmidt B, Blumenstein M. Monocyte phenotype and interleukin-1 production in patients undergoing hemodialysis. Nephron 1991; 59: 573-9.
19. Beekhuizen H, Blokland I, Corsel-Van Tilburg AJ, Koning F, Van Furth R. CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells. J Immunol 1991; 147: 3761-7.
20. Allen ML, Peters MJ, Goldman A, et al. Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit Care Med 2002: 30: 1140-5.
21. Ditschowski M, Kreuzfelder E, Rebmann V, et al. HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg 1999; 229: 246-54.
22. Rabb H, Agosti SJ, Pollard S, Bittle PA, Ramirez G. Activated and regulatory T lymphocyte populations in chronic hemodialysis patients. Am J Kidney Dis 1994; 24: 443-52.
23. Depisch R, Gohl H, Smeby L. Microdomain structure of polymeric surfaces-potential for improving blood treatment procedures. Nephrol Dial Transplant 1998; 13: 1362-4.
24. Schindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello CA. Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 1990; 37: 85-93.
25. Marchant A, Tielemans C, Husson C, et al. Cuprophane haemodialysis induces upregulation of LPS receptor (CD14) on monocytes: Role of complement activation. Nephrol Dial Transplant 1996; 11: 657-62.
26. Vienken J, Baumeister U. Improved biocompatibility of dialyzers by reduces membrane surface area. Artif Organs 1987; 11: 272-3.
27. Grootendrost AF, Van Bommel EFH, Van Der Hoven B, Van Leengoed LAMG, Van Osta ALM. High volume hemofiltration improves hemodynamics of endotoxin-induced shock in the pig. J Crit Care 1992; 7: 67-75.